Dr. David Starks
Claim this profileAvera Cancer Institute
Studies Ovarian Cancer
Studies Uterine Cancer
18 reported clinical trials
32 drugs studied
Area of expertise
1Ovarian Cancer
Stage IV
Stage II
Stage III
2Uterine Cancer
Stage I
Stage III
Stage IV
Affiliated Hospitals
Clinical Trials David Starks is currently running
Selinexor Maintenance Therapy
for Endometrial Cancer
The purpose of this study is to evaluate the efficacy and safety of selinexor as a maintenance treatment in patients with p53 wt endometrial carcinoma (EC), who have achieved a partial response (PR) or complete response (CR) (per Response Evaluation Criteria in Solid Tumors version 1.1 \[RECIST v 1.1\]) after completing at least 12 weeks of platinum-based therapy. A total of 276 participants will be enrolled in the study and randomized in a 1:1 ratio to maintenance therapy with either selinexor or placebo.
Recruiting1 award Phase 32 criteria
ZN-c3
for Serous Carcinoma
This is a multi-part Phase 2 study to evaluate the efficacy and safety of azenosertib (ZN-c3) in subjects with Platinum-Resistant, High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer. Part 2 of the study will be conducted in subjects whose tumors are Cyclin E1 positive as determined by central review using the Sponsor's investigational clinical trial assay.
Recruiting1 award Phase 21 criteria
More about David Starks
Clinical Trial Related7 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments David Starks has experience with
- Olaparib
- Pembrolizumab
- Carboplatin
- Paclitaxel
- Upifitamab Rilsodotin
- ELU001
Breakdown of trials David Starks has run
Ovarian Cancer
Uterine Cancer
Endometrial Adenocarcinoma
Endometrial Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Starks specialize in?
David Starks focuses on Ovarian Cancer and Uterine Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are Stage II.
Is David Starks currently recruiting for clinical trials?
Yes, David Starks is currently recruiting for 5 clinical trials in Sioux Falls South Dakota. If you're interested in participating, you should apply.
Are there any treatments that David Starks has studied deeply?
Yes, David Starks has studied treatments such as Olaparib, Pembrolizumab, Carboplatin.
What is the best way to schedule an appointment with David Starks?
Apply for one of the trials that David Starks is conducting.
What is the office address of David Starks?
The office of David Starks is located at: Avera Cancer Institute, Sioux Falls, South Dakota 57105 United States. This is the address for their practice at the Avera Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.